KERATOcONUS
MODERN TREATMENT 

The aim of modern keratoconus treatment is to improve visual acuity and to stop the progression of the disease.

MyoRing: To improve visual acuity.

The MyoRing is a crucial milestone in the treatment of keratoconus. MyoRing treatment is currently the most modern technology in this field....

>> more 

KERALUX Crosslinking: With still good visual acuity.

Keralux is currently the most modern crosslinking technology for stopping the progression of the keratoconus with good visual acuity and eliminates the usual sources of error in crosslink treatment such as head movements, eye movements and variation of the corneal steepness.

>> more

CICIS Keratoconus Center: The latest keratoconus treatment in Germany and Austria

MyoRing

MyoRing: Treatment of reduced visual acuity

... the latest technology for the treatment of keratoconic eyes where visual acuity is already impaired.

CISIS/MyoRing is the first and only technology which can achieve an improvement of vision and a termination of the progression of the disease. It is as permanent as laser treatment and as safe as contact lenses.

In keratoconic eyes suffering from already impaired vision, MyoRing treatment can improve the vision significantly. MyoRing is a complete ring made for an implantation into the cornea with the ability to eliminate irregularities within the diseased cornea. Due to its patented design as a complete ring implant, the MyoRing can also support the weakened cornea and therefore stop the progression of the disease.

The treatment is a short and minimally-invassive procedure performed under topical anesthesia (eye drops) only. It is free of pain (pre-operatively as well as post-operatively) and the tiny wound heals within a few hours without the need of a suture. No eye patch. No suture. MyoRing keratoplasty is among the safest surgical procedures in ophthalmology and can replace both contact lenses and corneal transplants in most cases. 

    MyoRing treatment is indicated

    • for the treatment of all stages of keratoconus
    • for the treatment of post-LASIK keratectasis
    • after corneal transplantation with an unsatisfactory outcome
    KERALUX Crosslinking

    KERALUX Crosslinking: For keeping still good visual acuity

    ... the latest technology for the treatment of keratoconic eyes where the disease is progressing but visual acuity is still sound.

    KERALUX Crosslinking allows a homogenous energy transfer even in the steepest and most affected areas of the cornea.

    Safe and effective: Conventional corneal crosslinking is a globally accepted therapy of keratoconus. The intention of corneal crosslinking is to stop the progression of the disease by stiffening the cornea. In order to achieve this, 5.4 J/cm2 of energy have to be transferred to the corneal tissue via UV-A light irradiation. In conventional crosslinking, the effective energy transferred to a certain point of the cornea depends on its steepness. Since the steepness of the cornea varies in keratoconic eyes and from patient to patient, conventional crosslinking is not able to provide the right amount of UV-A irradiation to all parts of the cornea. Unfortunately, this is particularly true for the steepest and most affected areas of the cornea. Treatment failure rates of up to 15% are reported.

    KERALUX Crosslinking is a new technology, which is able to ensure a homogenous UV-A energy transfer to all parts of the cornea, independent from its steepness. This is achieved by an irradiation channel, which reflects the UV-A irradiation and guarantees a homogenous energy transfer, rather than a free irradiation path used in conventional crosslinking.

    Click here to learn more about KERALUX Corneal Crosslinking.

    NEW! Telemedical consultation.

    Keratoconus is a rare condition. The MyoRing treatment in Germany is currently only carried out in Munich and Hamburg. Therefore, patients often have to travel from far away to clarify whether CISIS / MyoRing treatment is possible. Dr. Daxer, the specialist for treatment in Munich, now offers the opportunity to conduct a detailed discussion of the findings and the informational discussion telemedically using a video conference between the patient and Dr. Daxer. The patient must first collect the following examination data from his ophthalmologist on site: 1. Visual acuity with and without correction 2. Refraction 3. Pentacam images with corneal thickness and K values. This saves the patient the long journey! If the telemedical consultation leads to the result that CISIS / MyoRing treatment is possible and sensible, an appointment for an intervention with Dr. Daxer can be arranged in Munich. Immediately before the intervention, the examination data are precisely determined and checked and checked with Dr. Daxer discussed. Inquiries for telemedical advice from Dr. Daxers can be contacted by email at info@cisis.com, via the contact form on this website or by phone on 0800 222 78 66 (Mon - Thu from 8.30 a.m. to 12.30 p.m.).

    CISIS Keratoconus Centre 
    Munich

    Aschauer Straße 30
    München,  81549


    Phone 0800 222 78 66

    (Mo - Thu 08:30 - 12:00)

    Free of Charge from Austria and Germany

    CISIS Keratoconus Centre 
    Ybbs

    A-3370 Ybbs
    Stauwerkstrasse 1

    Phone 0800 222 78 66
    (Mo-Thu 08:30 - 12:00)
    Free of Charge from Austria and Germany

    CISIS Keratoconus Centre 
    Wels

    A-4600 Wels
    Salzburger Strasse 65

    Phone 0800 222 78 66
    (Mo-Thu 08:30 - 12:00)

    Free of Charge from Austria and Germany

    Information about Cookies and Data Protection:

    This website uses cookies. Cookies are small pieces of text, a web browser stores on the user’s device. They cause no harm.

    Cookies that are required for the functionality of the website are set in accordance with Art 6 para. 1 lit b) GDPR (legal basis). All other cookies are only stored providing that you give consent according to Art 6 para. 1 lit a) GDPR (legal basis).


    You have the right to withdraw your consent at any time. The withdrawal of consent does not affect the lawfulness of processing based on consent before its withdrawal. You are not obliged to give your consent in order to use the website. You can use the website irrespectively of your given, refused or withdrawn consent. However, the functionality of the website may be limited, when you refuse or withdraw your consent.


    The offered information on this website is not addressed to children and persons below the age of 16.


    To withdraw your consent or to restrict cookies, you have particularly the following possibilities:

    Necessary Cookies:

    This website could use the following cookies that are essential for operating the website:


    Optional cookies for marketing and analysis purposes:


    Cookies that are set for marketing and analysis purposes usually are stored longer than for the particular session; the precise storage time can be learned from the guidelines of the respective providers.

    Additional information about the utilization of personal data in connection with the usage of this website can be found in our Data Protection Guidelines in accordance with Art 13 GDPR.